Recent reports have shown that high nuclear expression of HDGF facilitates the progression and poor prognosis in some primary cancers, including hepatocellular [19], gastric [20], pancreatic [21], non-small-cell lung cancers [22], and gastrointestinal stromal tumors [23]. The gene discussed is HDGF; the disease is non-small cell lung carcinoma.